Connect with us

Technology

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL’s Galleri® Multi-Cancer Early Detection (MCED) Test

Published

on

MENLO PARK, Calif., May 12, 2025 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with athenahealth, a leading provider of network-enabled software and services for healthcare practices and systems nationwide. This collaboration will integrate ordering of GRAIL’s Galleri® multi-cancer early detection (MCED) test into athenaCoordinator Core, a service designed to help streamline laboratory order transmission and care coordination for healthcare facilities. The integration will be provided through athenaOne, athenahealth’s leading cloud-based electronic health record (EHR) solution.

Integration with athenaCoordinator Core will allow over 160,000 U.S. clinicians on the athenahealth network to opt in to more seamlessly order Galleri directly in the EHR, reducing additional ordering steps. After the clinician’s order is placed, the patient can take the Galleri test kit to a blood draw appointment. The Galleri test results will be made available automatically in the patient chart, reducing manual entry and administrative burden for the clinician’s practice.

“Cancer remains a public health crisis. There is a clear need to transform the way we screen for cancer while still asymptomatic, when it can be more easily treated,” said Josh Ofman, MD, MSHS, president at GRAIL. “Integrating with athenaCoordinator Core will help simplify the Galleri test ordering process as part of routine exams and help increase patient access to multi-cancer early detection to screen for some of the deadliest cancers before they become symptomatic.”

Cancers growing in the body shed DNA into the bloodstream. These DNA fragments act like a unique “fingerprint” of cancer. With a single blood draw, the Galleri test screens for the “fingerprint” of many of the deadliest cancers before they become symptomatic, including those with no recommended screening tests today. It can also provide doctors with information on the cancer’s origin to help predict the tissue type or organ associated with the cancer signal. The Galleri test is prescription only, recommended for adults with an elevated risk for cancer, such as those age 50 or older, and is to be used in addition to recommended cancer screenings.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

About Galleri®
The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique “fingerprint” of cancer, to help screen for some of the deadliest cancers that don’t have recommended screening today, such as pancreatic, esophageal, ovarian, liver, and others.* The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer, giving healthcare providers a roadmap of where to explore further. The Galleri test requires a prescription from a licensed healthcare provider and should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test, or cervical cancer screening. The Galleri test is recommended for adults with an elevated risk for cancer, such as those aged 50 or older.

For more information, visit galleri.com.

Sensitivity in study participants with –
Pancreas cancer: 83.7% overall (61.9% stage I, 60.0% stage II, 85.7% stage III, 95.9% stage IV). Esophagus cancer 85.0% overall (12.5% stage I, 64.7% stage II, 94.7% stage III, 100% stage IV). Ovary cancer: 83.1% overall (50.0% stage I, 80.0% stage II, 87.1% stage III, 94.7% stage IV). Liver/bile duct cancer: 93.5% overall (100% stage I, 70.0% stage II, 100% stage III, 100% stage IV).

Important Galleri Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

Laboratory/Test Information
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

Forward Looking Statements
This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “aim,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should,” “would,” or “will,” the negative of these terms, and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties, and assumptions about us, may include expectations about or projections ease of ordering Galleri, potential increases in patient access, clinical impact, technology, clinical and real world studies, regulatory compliance, potential market opportunity, anticipated growth strategies, and other topics.

These statements are only predictions based on our current expectations and projections about future events and trends. There are important factors that could cause our actual results, level of activity, performance, or achievements to differ materially and adversely from those expressed or implied by the forward-looking statements, including those factors and numerous associated risks discussed under the section entitled “Risk Factors” in our Annual Report on Form 10-Q for the period ended March 31, 2025 and our Form 10-K for the period ended December 31, 2024 (the “Form 10-K”). Moreover, we operate in a dynamic and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results, level of activity, performance, or achievements to differ materially and adversely from those contained in any forward-looking statements we may make.

Forward-looking statements relate to the future and, accordingly, are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Although we believe the expectations and projections expressed or implied by the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update any of these forward-looking statements after the date of this press release to conform our prior statements to actual results or revised expectations or to reflect new information or the occurrence of unanticipated events.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-and-athenahealth-team-up-to-offer-healthcare-providers-streamlined-ordering-of-grails-galleri-multi-cancer-early-detection-mced-test-302452612.html

SOURCE GRAIL, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

REPT BATTERO Deepens Inter Milan Partnership, Brings Latest Innovations to Intersolar Europe 2026

Published

on

By

MUNICH, June 20, 2026 /PRNewswire/ — As global audiences follow the world’s biggest football tournament this summer, another international stage is preparing to bring together innovators, businesses and industry leaders from across the energy sector.

From June 23 to 25, REPT BATTERO will participate in Intersolar Europe 2026 in Munich, Germany, showcasing its latest developments in energy storage, sustainability and global business expansion.

Adding to the excitement, an Inter Milan legend will make a special appearance at the REPT BATTERO booth, meeting customers, partners and visitors from around the world. The appearance follows the company’s recent partnership with Inter Milan, which named REPT BATTERO as the club’s Global Official Battery and Energy Storage Partner.

But beyond products, exhibitions and football, the story REPT BATTERO hopes to tell is about something larger: how a young Chinese battery company is evolving into a global energy brand.

Growth Comes First

For any company looking to expand globally, one question comes before all others: is the business ready?

For REPT BATTERO, the answer is increasingly being reflected in its performance.

According to its 2025 annual results, the company reported revenue of approximately €3.1 billion, up 36.7% year on year, while net profit reached approximately €87 million, marking the company’s first full year of profitability. Annual battery shipments totaled 82.7GWh, representing year-on-year growth of 89.2%.

Energy storage continued to be a key growth driver, generating approximately €1.7 billion in revenue in 2025, an increase of 86.8% compared with the previous year.

The momentum has continued into 2026. In the first quarter, REPT BATTERO ranked No.1 globally in both residential energy storage cell shipments and commercial & industrial energy storage cell shipments, while ranking among the world’s top five in energy storage cell shipments overall. The company has also maintained BloombergNEF Tier 1 Energy Storage Supplier status for eleven consecutive quarters.

These achievements are not simply the result of rapid growth. They reflect years of investment in product development, manufacturing capability, customer relationships and operational excellence.

For REPT BATTERO, globalization is not a sudden ambition. It is the natural next stage of a business that has steadily built the foundations required to compete internationally.

Globalization Beyond Exporting Products

For many companies, globalization begins with exports.

But long-term success requires much more than shipping products overseas.

Customers increasingly evaluate suppliers not only on technology and price, but also on local service capabilities, supply chain resilience, regulatory readiness and long-term reliability. This is particularly true in Europe, where the energy transition continues to drive demand for trusted and sustainable partners.

Over the past several years, REPT BATTERO has been steadily strengthening its international footprint.

The company established its European subsidiary in Munich in 2023 and has since expanded its overseas presence across Germany, the United States, Indonesia, Australia and Japan. Today, REPT BATTERO’s business network spans six continents, supporting customers across a wide range of energy storage and mobility applications.

At the same time, the company is advancing construction of its first overseas manufacturing base in Indonesia, a major milestone in its global manufacturing strategy.

Europe remains one of REPT BATTERO’s most important markets. Earlier this year, during KEY – The Energy Transition Expo in Italy, the company signed energy storage supply agreements totaling 8.3GWh with seven European partners. REPT BATTERO has successfully delivered and deployed energy storage projects in Germany, Belgium, Slovakia, Romania, Bulgaria, Greece, Ukraine, Poland, Moldova and Latvia, further strengthening its presence in Europe.

Taken together, these developments demonstrate that REPT BATTERO’s global strategy extends far beyond exports. The company is building local presence, local partnerships and long-term capabilities designed to support customers worldwide.

Building a Global Brand

As technology, products and services enter global markets, another challenge emerges: building recognition and trust.

This is one of the reasons behind REPT BATTERO’s partnership with Inter Milan.

Announced in May 2026, the collaboration goes beyond traditional sponsorship. It includes brand campaigns, fan engagement initiatives, customer experiences and future activations across international markets.

For REPT BATTERO, the partnership represents a new approach to global brand building.

Historically, battery companies have communicated primarily through technical specifications, product performance and manufacturing capabilities. While these remain essential, global audiences increasingly connect with brands through stories, experiences and shared values.

Football provides a unique platform for that connection.

With one of the largest fan bases in world football, Inter Milan offers a global stage that transcends language, geography and culture. Through the partnership, REPT BATTERO aims to engage customers and communities in a more accessible, international and human-centered way.

The goal is not simply to increase visibility. It is to help a broader audience understand the innovation, ambition and long-term vision behind the company.

Youth Is About Agility, Not Image

Founded in 2017 and entering production just one year later, REPT BATTERO remains a relatively young company by industry standards.

Yet its development has been remarkably rapid.

The company became one of the fastest battery manufacturers in the industry to surpass RMB 10 billion in annual revenue. Since then, it has continued evolving—from rapid expansion to profitability, from domestic growth to international development, and from product exports to global brand building.

At REPT BATTERO, being young is not about image. It is about agility.

It means responding quickly to changing market conditions, adapting to customer needs and continuously improving across products, operations and organization.

Whether addressing growing demand for residential energy storage in Europe, preparing for emerging battery passport requirements, or navigating an industry increasingly focused on profitability and sustainable growth, REPT BATTERO has consistently demonstrated its ability to adapt and execute.

This combination of innovation, responsiveness and global ambition continues to shape the company’s identity as it enters its next stage of development.

See You in Munich

From SNEC in Shanghai to Intersolar Europe in Munich, the interaction between REPT BATTERO and INTER MILAN continues.

Yet the company’s story is about more than exhibitions or celebrity appearances. It is about the evolution of a young energy company building the capabilities, partnerships and brand needed to compete on a global stage.

This June, as the FIFA World Cup captures the attention of football fans around the world, REPT BATTERO will welcome an Inter Milan legend to its booth at Intersolar Europe in Munich.

When a player who once stood at the pinnacle of world football walks into the booth of a young Chinese energy company and exchanges handshakes and conversations with customers and partners from across the globe, the moment represents something larger than a partnership.

It reflects how far REPT BATTERO has come—and where it is heading next.

From a fast-growing battery manufacturer to an increasingly global energy brand, REPT BATTERO’s journey is still being written. And perhaps, that scene in Munich will be one of its most meaningful chapters yet.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/rept-battero-deepens-inter-milan-partnership-brings-latest-innovations-to-intersolar-europe-2026-302805755.html

Continue Reading

Technology

Felicitysolar Strengthens Brand Presence at SNEC 2026

Published

on

By

GUANGZHOU, China, June 20 2026 /PRNewswire/ — Felicitysolar presented its energy storage product portfolio, technical progress, third-party recognition, and global cooperation achievements at SNEC 2026, held in Shanghai from June 3 to June 5.

During the exhibition, Felicitysolar showcased solutions for residential, commercial, and industrial energy applications, including the 50kW C&I ESS, 125kW/257kWh system, 125kW/261kWh liquid-cooled all-in-one system, and FLB Series low-voltage residential battery pack. These products reflected the company’s continued focus on system reliability, flexible deployment, and practical energy storage needs across different scenarios.

Felicitysolar also held Chinese and English product presentations on June 3 and June 4, covering commercial and industrial energy storage systems, low-voltage residential battery packs, intelligent management platforms, and the company’s newly developed AI management platform. Through application-oriented explanations, the presentations helped customers better understand the role of Felicitysolar’s products in residential, commercial, and industrial energy management.

Third-party activities during the exhibition added further depth to Felicitysolar’s brand presentation. Intertek issued ETL certificates for Felicitysolar’s energy storage system and photovoltaic inverter products and granted the company Intertek “Satellite Program” laboratory qualification, supporting product access to the North American market and recognizing Felicitysolar’s in-house testing capability. DEKRA presented certificates related to Felicitysolar’s hybrid inverter and energy storage battery system products for European and international standards. SGS granted an Australian grid-connection certificate for Felicitysolar’s IVGM25KHP3G3 Series high-voltage hybrid inverter. EUPD Research recognition was also presented during the exhibition.

In addition, Felicitysolar received three Global Smart Energy Award honors: ENTERPRISE OF THE YEAR, FRONTIER TECHNOLOGY, and INNOVATIVE SOLUTION. These awards recognized Felicitysolar’s overall development, the FLB Series low-voltage LiFePO4 battery pack, and the 50kW high-voltage hybrid energy storage system, respectively. Together with the third-party activities, the awards highlighted Felicitysolar’s continued progress in product development, quality systems, market readiness, and solution capabilities.

The company also held partner signing ceremonies for Argentina and Chile, strengthening communication and cooperation with partners in Latin America. As energy storage demand grows across regional markets, localized cooperation remains an important part of Felicitysolar’s global development.

To extend the exhibition experience beyond the venue, Felicitysolar launched an online VR booth tour, allowing customers to explore the booth layout, featured products, and related materials after the event:
https://www.felicitysolar.com/snec-pv-power-expo-shanghai-vr-tour/

Through product showcases, technical presentations, third-party activities, award recognition, localized partnerships, and digital exhibition tools, Felicitysolar used SNEC 2026 to present its brand capabilities in solar energy storage. The company will continue to focus on practical energy needs across residential, commercial, and industrial applications while strengthening its products, services, and global cooperation capabilities.

About Felicitysolar

Founded in 2007 and headquartered in Guangzhou, China, Felicitysolar provides solar energy storage solutions for residential, commercial, and industrial applications. Its product portfolio covers solar inverters, lithium battery packs, integrated solar street lights, commercial and industrial energy storage systems, and related smart energy solutions.

CONTACT:
Felicitysolar Marketing Department
pr@felicitysolar.com
+86-18620102298

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/felicitysolar-strengthens-brand-presence-at-snec-2026-302805745.html

Continue Reading

Technology

Alcott HR Appoints Michael Pascucci as Director of Strategic Projects

Published

on

By

FARMINGDALE, N.Y., June 19, 2026 /PRNewswire/ — Alcott HR announces Michael Pascucci as Director of Strategic Projects. Michael brings over ten years of experience in HR operations and project management.

Before joining Alcott HR, he held senior roles leading technology upgrades and launching new employee benefits programs. This experience supports Alcott’s initiatives, helping the company grow while putting clients first.

 As Director, Michael drives operational excellence at Alcott HR by leading strategic projects. He maintains processes to ensure Alcott stays flexible and personalized during growth. Michael focuses on projects that further enhance client support.

Improving Data Accuracy:  Michael connects Alcott’s main systems with partners. Automating these connections streamlines onboarding and enrollment, ensuring benefits and payroll are accurate and secure. This gives clients confidence their information is in good hands.

Creating a Seamless Client Experience:  Michael is improving how Alcott manages projects and client renewals. With consistency in these processes, Alcott delivers a seamless, dependable experience, especially during year-end reporting and enrollment.

Building for Growth:  By replacing manual tasks with digital solutions, Michael helps Alcott grow with its clients. This allows the team to focus on building relationships and offering expert HR guidance to help clients achieve their goals.

“Michael doesn’t just manage projects, he builds systems that help our team excel,” said Kristen Bartolotta, Sr. Director of Operations at Alcott HR. “His ability to transform complex processes into streamlined solutions has improved our efficiency and enhanced our client service.”

“Working with the talented Alcott team has been a great experience,” said Michael Pascucci. “I’m excited to continue working across departments to improve our processes, boost efficiency, and help the company keep growing.”

Through these efforts, Michael helps Alcott deliver even greater value to clients by driving innovation, strengthening relationships, and ensuring every organization can reach its potential.

About Alcott HR: Alcott HR is an IRS Certified* and ESAC Accredited, Professional Employer Organization that provides a comprehensive range of human resources solutions to small and mid-sized businesses. With nearly four decades of experience, Alcott HR offers customized services that allow businesses to manage their workforce more effectively while staying compliant with state and federal regulations. Their services include payroll, benefits, risk management, and HR support, designed to help businesses grow and succeed.

The IRS does not endorse any particular certified professional employer organization.

Media Contact:
Sarah Zulawski
Marketing Specialist
szulawski@alcotthr.com 
(716) 241-8893 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alcott-hr-appoints-michael-pascucci-as-director-of-strategic-projects-302805721.html

SOURCE Alcott HR

Continue Reading

Trending